Clinical trial · Interventional
Role of Routine Nasogastric Decompression After Subtotal Gastrectomy
NCT00164918CI-TRIAL-00000137unknownPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to evaluate whether subtotal gastrectomy without post-operative nasogastric decompression is better in terms of early post-operative bowel function and chest complication.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer of Stomach | Malignant Gastric Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| nasogastric tube | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Bowel function and related symptoms early post-op
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Weeks
Show eligibility criteria text
Inclusion Criteria:All patients suffering from carcinoma of stomach, decided for operation * subtotal, D1/D2 dissection * palliative resection Exclusion Criteria: * actively bleeding tumor * perforation of tumor * patient present with gastric outlet obstruction * combine organ excision * known diabetes with nephropathy
References
Publications (0)
Data not yet available
No reference posted for this study.